
AABB
@AABB
Followers
11K
Following
17K
Media
3K
Statuses
13K
AABB is a not-for-profit association representing institutions and individuals working in transfusion medicine and biotherapies. #AABB2025 #AABBjc #AABBcabp
Bethesda, MD
Joined August 2010
Pavement or pillow? 🏃♀️💤 Your choice! Either way, you’re supporting lifesaving blood and biotherapies research. Don’t miss the AABB Foundation’s Run (or Sleep-in) for Research at #AABB2025 in San Diego. Register: https://t.co/h3DPyWWzM6
0
1
1
They’re here! The #AABB2025 abstracts are now available in an online supplement to the September issue of Transfusion. Take a sneak peek at the latest research in #bloodbanking, #transfusion and #biotherapies: https://t.co/XCR7pDbWRi
0
0
0
Legends Don’t Follow, They Lead. FlyQuest x Von Dutch Worlds 2025 Collection available now.
80
87
1K
A new class of biotherapies leaders is transforming advanced therapies. 🧬 Our latest case study shows how. 🧭 Meet the #AABBcabp recipients, discover what inspired them to earn the CABP credential, and see how it’s shaping their work and organizations. https://t.co/3iZM38q7KI
0
0
3
Thousands of attendees, thousands of reasons to attend the AABB Annual Meeting! 💡 For @chloeirena, it’s an experience that keeps her coming back. Read her AABB News feature to find out why: https://t.co/K8HPngEnDG
#Transfusion #BloodBanking #Biotherapies #AABB2025
0
1
3
What role do platelets play in sickle cell disease? 🔬 Sean X. Gu, MD, PhD, with support from the AABB Foundation, is studying how platelets interact with the immune system to identify new therapeutic targets for vaso-occlusive crises. Learn more: https://t.co/7kdcpJ6Hs4
0
1
2
TRAILER: The Story of SermonAudio Discover the remarkable journey of how SermonAudio began with a young boy in the 1980s who fell asleep each night listening to cassette tapes of preaching—a simple beginning that would, by God's providence, grow into a global platform reaching
0
4
13
Don’t miss the latest AABB News. 🩸 Articles this month explore gene therapy in pediatric #SCD with @ChildrensNatl, bridging the gap in SCD care, and future of patient blood management programs in pediatric care. Start reading: https://t.co/vSHLDn4S0H
0
0
1
Biotherapies are evolving fast. Are you keeping up? We asked @DKalodimou, chair of #AABB2025’s cellular therapy program, to share top five can’t-miss events that will shape the future of cell and gene therapy, MSCs and cord blood. Explore her picks: https://t.co/8EKGjrWTJc
0
0
1
I’m honored to be featured in an AABB case study highlighting the Certified Advanced Biotherapies Professional (CABP) credential. @AABB @MSKPathology @MSKCancerCenter
0
1
5
📢 Starting in 2026, the journal Transfusion is moving to online with the option for print on demand! Don't miss a single issue by setting up your e-alerts! Click on "Sign up for email alerts" on the right-hand side of the journal homepage: https://t.co/sK7a1nSiUX
@AABB
0
1
2
What’s next in molecular immunohematology? 🔬 Join AABB and Grifols for a complimentary Science & Innovation Forum that explores how innovations in modern-day genotyping help provide safer transfusions. 🗓️ Oct. 9 | 11 a.m.–12 p.m. ET https://t.co/IDQS2OFuQb
aabb.org
Learn through examples how innovations in modern-day genotyping help provide safer transfusions for the simple to complex transfusion recipient.
0
1
1
A new CellSource is here! ✨ This month, AABB's Christina Celluzzi and BBG Advanced Therapies' Heather Munoz discuss access to cell and gene therapies, AABB releases a new CABP case study, and new #CGT Standards for Pharmacy take effect Oct. 1. Dive in: https://t.co/ciJ6XK03nu
0
0
1
The AI agent wars are heating up! @JasonTAndersen, VP & Principal Analyst at @MoorInsStrat, shares his take on two major drops: @SAP is getting specific with unique role-based agents (think HR peer-to-peer routing for onboarding and benefits!), while @Google just made a
1
0
0
SCD affects more than 100K people in the U.S., yet their stories are often unheard. Today, Marjorie Dejoie-Brewer, MD, a physician and sickle cell warrior, takes over AABB’s Instagram to share her story and highlight the power of advocacy. Follow along: https://t.co/UaYawmW8X5
0
0
1
Advancing quality worldwide! 🌍 We recently welcomed leaders from Georgia to our national office to exchange information on blood donation, manufacturing and transfusion medicine to support the country’s transition to a volunteer blood donation system. https://t.co/ILvjkDwcur
0
0
0
Marjorie Dejoie-Brewer, MD, sickle cell warrior, physician and advocate, is taking over AABB’s Instagram on Tuesday. 💬 Hear her journey. 🤝 Learn advocacy strategies. 💡 See how one voice can spark change. Meet Dr. Dejoie-Brewer: https://t.co/OqF1sDKfKU
0
1
4
The #AABB2025 Biotherapies Pavilion is where experts connect and the future of biotherapies comes into focus. ☕ CABP Coffee Morning 🎯 Final CT Jeopardy! 💡 Open-mic sessions on cell collection, sourcing + organoids View the schedule: https://t.co/zaeWb8DRtx
0
0
4
Here's our new graphic on which U.S. allies can help the U.S. diversify its critical minerals supply chains away from China. Straight from our new report on allies and strategic competition with China:
2
7
32
Your next opportunity could be one conversation away. 💬 Meet leading employers in blood banking, transfusion medicine + biotherapies at AABB’s fall career fairs. 💻 Virtual: Oct. 8 📍 In person: Oct. 26–27 during #AABB2025 Learn more + register today: https://t.co/NXFeIqKqQr
0
0
1
No lab can be perfectly sterile, but common aseptic technique myths can increase your risk of contamination. Discover the truth in our latest AABB News article: 6 Common Myths (and the Facts That Could Save Your Lab): https://t.co/p2ApszskTH
0
0
0
Start your morning with a run 🏃… or catch some extra Zzz’s 😴. Either way, you’ll help power the future of blood and biotherapies research at #AABB2025! Join the #AABBFoundation Run (or Sleep-In) for Research: https://t.co/h3DPyWWzM6
0
0
1
🎙️ Investor Spotlight: Why Calidi Biotherapeutics $CLDI Is a Company to Watch Eric Poma, PhD, CEO of @CalidiBio, breaks down the company’s innovative approach to fighting cancer using proprietary stem cell-based platforms to deliver powerful oncolytic viruses. Why It Matters
0
1
4
A new issue of #Transfusion is here! 🔬 Research in this issue explores PBSC collections in the very smallest patients, ABO gene methylation and plasma protein levels, and alloimmunization rates in pregnancy. Start reading: https://t.co/H4LbuFg11g
0
0
2